| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/15/2001 | WO2001011035A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011013A2 The interaction of smad6 with hox proteins and uses thereof |
| 02/15/2001 | WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 02/15/2001 | WO2001011006A2 Detection of micro-organisms |
| 02/15/2001 | WO2001010910A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 02/15/2001 | WO2001010909A1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010900A2 Globular assembly of amyloid beta protein and uses thereof |
| 02/15/2001 | WO2001010898A2 Compositions and methods for regulating the cell cycle and other cellular processes involving the tgf-beta family |
| 02/15/2001 | WO2001010888A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | WO2001010884A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
| 02/15/2001 | WO2001010881A1 Fluorogenic compounds and uses therefor |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010468A2 Drug-carrier complexes and methods of use thereof |
| 02/15/2001 | WO2001010457A2 Pharmaceutical compositions containing tripeptides |
| 02/15/2001 | WO2001010456A2 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010386A2 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof |
| 02/15/2001 | WO2001010384A2 Method for identifying compounds for treatment of insulin resistance |
| 02/15/2001 | WO2000075361A3 Method to determine the toxicity caused by exposure to chemical and physical agents |
| 02/15/2001 | WO2000068687A3 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/15/2001 | WO2000067872A3 High throughput crystal form screening workstation and method of use |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000063296A3 Cyanine dyes and synthesis methods thereof |
| 02/15/2001 | WO2000058733A3 Assay for testing the efficacity of a therapy |
| 02/15/2001 | WO2000057900A3 Factor for regulation of neurite growth |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000049416A3 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO2000039154A8 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 02/15/2001 | WO2000011204A3 Homer interacting proteins |
| 02/15/2001 | DE19942436A1 Process for estimating the spread of pollutants comprises using concentration measurements along the flow direction of the waste stream of the polluted area and observing the development in concentration gradient |
| 02/15/2001 | DE19938384A1 Detecting analytes or binding reactions, useful e.g. for diagnosis, based on measuring relaxation of birefringence of magnetic marker compounds |
| 02/15/2001 | DE19937778A1 Characterizing the functional state of living cells, especially tumor cells, comprises analyzing multiparametric data and comparing the resulting signal patterns with pre-established patterns |
| 02/15/2001 | DE19937318A1 Gas analysis comprises taking conductance-time profiles in a first calibration step depending on the concentration, carrying out a post-calibration and comparing the measuring curves with the calibration curves to identify the gas component |
| 02/15/2001 | DE19936003A1 Lentivirus aus der Gruppe der Immunschwächeviren der Drillaffen(mandrillus leucophaeus) und ihre Verwendung Lentivirus from the group of immunodeficiency viruses of the drill monkey (mandrillus leucophaeus) and their use |
| 02/15/2001 | DE19932958A1 Vorrichtung zur Bindung von Molekülen, Molekülgruppen, Molekülteilen und/oder Zellen A device for binding molecules, molecular groups, molecular parts and / or cells |
| 02/15/2001 | DE19924637C1 Vorrichtung sowie Meßverfahren zum Messen des Dehn- oder Kontraktionsverhaltens von fadenförmigem Prüfgut Apparatus and measuring method for measuring the stretching or contraction behavior of filamentary test material |
| 02/15/2001 | DE19913270A1 Process for determining gaseous emissions from e.g. manure, comprises inducing additional gaseous emissions on, in or under the surfaces to be investigated, and installing a gas sampling system above the surface to be investigated |
| 02/15/2001 | CA2419714A1 Direct aspiration-reaction and injection device and methods of use |
| 02/15/2001 | CA2384744A1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381910A1 Novel vitamin d analogues |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381455A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381271A1 Microsensor housing |
| 02/15/2001 | CA2381226A1 Method of recording gene analysis data |
| 02/15/2001 | CA2381204A1 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | CA2380646A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 02/15/2001 | CA2380398A1 Annexins and autoantibodies used as markers for cancer |
| 02/15/2001 | CA2379608A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | CA2379176A1 Methods for characterizing, classifying, and identifying unknowns in samples |
| 02/15/2001 | CA2379165A1 Chimeric proteins |
| 02/15/2001 | CA2378481A1 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | CA2378480A1 Pharmaceutical compositions containing tripeptides |
| 02/15/2001 | CA2378460A1 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | CA2378032A1 Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb) |
| 02/15/2001 | CA2374745A1 Proteases and protease inhibitors |
| 02/15/2001 | CA2373814A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/14/2001 | EP1076240A1 Method for assaying crp with the use of phosphorylcholine |
| 02/14/2001 | EP1076091A1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/14/2001 | EP1075841A1 Pneumococcal vaccines |
| 02/14/2001 | EP1075673A1 Methods of determining protein activity levels using gene expression profiles |
| 02/14/2001 | EP1075662A2 Methods for diagnosing and evaluating cancer |
| 02/14/2001 | EP1075661A1 Ligand binding assay and kit with a separation zone for disturbing analytes |
| 02/14/2001 | EP1075660A1 Miniature immuno-optical rapid analyte sensor platform |
| 02/14/2001 | EP1075659A1 Device for the collection, storage and/or transport of gas samples |
| 02/14/2001 | EP1075656A1 Detection of a target in a sample |
| 02/14/2001 | EP1075650A1 Device for measuring the stickiness of a flowable medium |
| 02/14/2001 | EP1075649A1 Device for enriching particles in a body fluid |
| 02/14/2001 | EP1075648A1 Sample collection method |
| 02/14/2001 | EP1075551A1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 02/14/2001 | EP1075550A1 Method for identifying and representing interindividual differences of dna sequences |
| 02/14/2001 | EP1075544A1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
| 02/14/2001 | EP1075543A2 Reduced complexity nucleic acid targets and methods of using same |
| 02/14/2001 | EP1075541A1 Electronic detection of nucleic acids using monolayers |
| 02/14/2001 | EP1075539A1 7-alkoxycoumarins as cytochrome p450 substrates |
| 02/14/2001 | EP1075536A1 Methods for identifying pathways of drug action |
| 02/14/2001 | EP1075535A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075526A1 Putative lactamase proteins from mouse and human |
| 02/14/2001 | EP1075523A2 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2001 | EP1075519A2 Inhibitors of nf-kb activation |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP1075485A1 A process to study changes in gene expression in t lymphocytes |
| 02/14/2001 | EP1075455A2 Method and device for nonsynthetic deconvolution |
| 02/14/2001 | EP1075327A1 Redrawn capillary imaging reservoir |
| 02/14/2001 | EP1075286A2 13c glucose breath test for the diagnosis of diabetes |
| 02/14/2001 | EP0787301B1 Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen |
| 02/14/2001 | EP0782706B1 Assay method |
| 02/14/2001 | EP0711294B1 Use of diazapentalene derivatives as reagents specific for thiol compounds |